My team and I just finished an awesome planning session for 2016. We spent eight hours masterminding about how to expand in 2016, so that we can better serve our clients, partners, and readers.
Have you done your 2016 planning yet?
Whether or not you have, I suggest that you do Grant Cardone’s “What Could I Do to Make More Money Exercise?”
As Grant writes:
“When I do this I only look at income possibilities not how to cut expenses. I am not trying to get smaller, I am trying to expand. The question is anything to do with expansion and acquisition. How do I get in front of more people, help more people, collaborate with the right people and ultimately grow the company. This is NOT an exercise of how to make more money by cutting expenses.”
That exercise will teach you how we think.
It is the reason that we are the leading provider of stem cell market intelligence, have the fastest growing stem cell account on Twitter (@StemCellMarket), are a Top Influencer for Stem Cells on LinkedIn, and dominate Google Search for a 1,000+ stem cell terms.
For us, 2016 will be all about EXPANSION, not about contraction.
About Us
BioInformant is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been featured on news outlets including the Wall Street Journal, Nature Biotechnology, Xconomy, and Vogue Magazine. Serving industry leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.